IMP: Explanation for business results in Quarter 4/2011

Imexpharm Pharmaceutical Joint Stock Company has explained the fluctuation over 10% of profit after tax in Quarter 4/2011 compared with in Quarter 4/2010 consolidated as follows:

- Net revenue increased by 1.44%, cost of goods sold decreased by 5.27% leading to gross profit increased by 9.96% or by VND10.61 billion. Beside, selling expenses increased by 8.13%, administrative expenses increased by 6.12%. Financial expenses decreased by 189.04%, other income decreased 53.08% because Company delayed the short-term and long-term financial provision, leading to profit before tax increased by 34.94% or by VND7.26 billion.

- However, corporate income tax expenses in Quarter 4/2011 increased by VND9.19 billion compared to Quarter 4/2010 as the firm was levied a tax rate of 25% from 2011 and the Cephalosporin factory in Binh Duong did not enjoy tax exemption in the period. Therefore, profit after tax in Q4/2011 was down by VND1.92 billion or by 13.94% from Q4/2010. 

hose

>   APC: Explanation for business result in Q4/2011 (consolidated) (09/03/2012)

>   TRC: Explanation for profit in Q4/2011 (09/03/2012)

>   PIT: Resolution of the BOD (09/03/2012)

>   VTF: Resolution on organizing the AGM 2012 (09/03/2012)

>   VPH: Notice of Annual General Meeting of Shareholders 2012 (09/03/2012)

>   TTF: Change of The date for the 2012 Annual General Meeting of Shareholders (09/03/2012)

>   TAC: Resolution on organizing the AGM 2012 and and the payment for 2011 (09/03/2012)

>   OGC: Resolution on organizing the AGM 2012 (09/03/2012)

>   NTB: Resolution on organizing the AGM 2012 (09/03/2012)

>   DPM: The record date for the 2012 Annual General Meeting of Shareholders (09/03/2012)